129 related articles for article (PubMed ID: 3432562)
1. Effect of BN 52063, a specific PAF-acether antagonist, on bronchial provocation test to allergens in asthmatic patients. A preliminary study.
Guinot P; Brambilla C; Duchier J; Braquet P; Bonvoisin B; Cournot A
Prostaglandins; 1987 Nov; 34(5):723-31. PubMed ID: 3432562
[TBL] [Abstract][Full Text] [Related]
2. Effects of PAF antagonist, BN52021, on the PAF-, methacholine-, and allergen-induced bronchoconstriction in asthmatic children.
Hsieh KH
Chest; 1991 Apr; 99(4):877-82. PubMed ID: 2009789
[TBL] [Abstract][Full Text] [Related]
3. Effect of PAF-acether inhalation on nonspecific bronchial reactivity and adrenergic response in normal and asthmatic subjects.
Hopp RJ; Bewtra AK; Nabe M; Agrawal DK; Townley RG
Chest; 1990 Oct; 98(4):936-41. PubMed ID: 2209152
[TBL] [Abstract][Full Text] [Related]
4. [Effect of the platelet-activating factor antagonist BN 52063 on exertional asthma].
Wilkens H; Wilkens JH; Uffmann J; Bövers J; Fröhlich JC; Fabel H
Pneumologie; 1990 Feb; 44 Suppl 1():347-8. PubMed ID: 2142294
[TBL] [Abstract][Full Text] [Related]
5. Effects of a PAF-antagonist (BN 52063) on bronchoconstriction and platelet activation during exercise induced asthma.
Wilkens JH; Wilkens H; Uffmann J; Bövers J; Fabel H; Frölich JC
Br J Clin Pharmacol; 1990 Jan; 29(1):85-91. PubMed ID: 2297463
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
Touvay C; Etienne A; Braquet P
Agents Actions; 1986 Jan; 17(3-4):371-2. PubMed ID: 3754380
[TBL] [Abstract][Full Text] [Related]
7. Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen.
Kuitert LM; Hui KP; Uthayarkumar S; Burke W; Newland AC; Uden S; Barnes NC
Am Rev Respir Dis; 1993 Jan; 147(1):82-6. PubMed ID: 8420437
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.
Lellouch-Tubiana A; Lefort J; Simon MT; Pfister A; Vargaftig BB
Am Rev Respir Dis; 1988 Apr; 137(4):948-54. PubMed ID: 3281530
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist.
Guinot P; Braquet P; Duchier J; Cournot A
Prostaglandins; 1986 Jul; 32(1):160-3. PubMed ID: 3763944
[TBL] [Abstract][Full Text] [Related]
10. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig.
Lagente V; Touvay C; Randon J; Desquand S; Cirino M; Vilain B; Lefort J; Braquet P; Vargaftig BB
Prostaglandins; 1987 Feb; 33(2):265-74. PubMed ID: 2438723
[TBL] [Abstract][Full Text] [Related]
11. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
12. PAF antagonism as an approach to the treatment of airway hyperreactivity.
Meade CJ; Heuer H
Am Rev Respir Dis; 1991 Mar; 143(3 Pt 2):S79-82. PubMed ID: 2003696
[TBL] [Abstract][Full Text] [Related]
13. Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses.
Evans DJ; Barnes PJ; Cluzel M; O'Connor BJ
Am J Respir Crit Care Med; 1997 Jul; 156(1):11-6. PubMed ID: 9230719
[TBL] [Abstract][Full Text] [Related]
14. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
Desquand S; Touvay C; Randon J; Lagente V; Vilain B; Maridonneau-Parini I; Etienne A; Lefort J; Braquet P; Vargaftig BB
Eur J Pharmacol; 1986 Aug; 127(1-2):83-95. PubMed ID: 3019727
[TBL] [Abstract][Full Text] [Related]
15. Platelet function: aggregation by PAF or sequestration in lung is not modified during immediate or late allergen-induced bronchospasm in man.
Hemmendinger S; Pauli G; Tenabene A; Pujol JL; Bessot JC; Eber M; Cazenave JP
J Allergy Clin Immunol; 1989 May; 83(5):990-6. PubMed ID: 2523922
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
[TBL] [Abstract][Full Text] [Related]
17. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
Braquet P
Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():179-98. PubMed ID: 2949548
[No Abstract] [Full Text] [Related]
18. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets.
Simon MF; Chap H; Braquet P; Douste-Blazy L
Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518
[TBL] [Abstract][Full Text] [Related]
19. Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses.
Freitag A; Watson RM; Matsos G; Eastwood C; O'Byrne PM
Thorax; 1993 Jun; 48(6):594-8. PubMed ID: 8346486
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings.
Adamus WS; Heuer HO; Meade CJ; Schilling JC
Clin Pharmacol Ther; 1990 Apr; 47(4):456-62. PubMed ID: 2328553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
